An observational study in Critical Illness, sponsored by Joseph D. Tobias. Completed at 1 site in United States. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-21.
Sponsored by Joseph D. Tobias · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study will use point of care (POC) gastric ultrasound to confirm that nasojejunal tube (NJ) feeds result in minimal to no gastric content and therefore are low risk for aspiration and should be allowed at the very least to decrease the time that enteral feeds need to be held prior to a procedure or if they need to be held at all. This would allow critically ill children to receive the nutrition that they need to heal for longer periods of time. Using ultrasound would also potentially eliminate the need for exposure to x-rays to confirm tube placement. Most ICUs have a POC ultrasound machine so this would be any easy tool to access to improve patient care.
1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.
This study's enrollment of 45 is below the median of 140 across 816 observational studies indexed under Critical Illness.
Browse Critical Illness studies →Joseph D. Tobias is the lead sponsor of 28 studies on the registry; 4 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 6 (100%) have results posted.
Counted across the registry records on this site, refreshed daily.
Critically ill children at Nationwide Children's Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Critically ill children receiving nutrition via a nasojejunal feeding tube.
Diagnostic Test: Ultrasound
Critically ill children receiving nutrition via a nasogastric feeding tube.
Diagnostic Test: Ultrasound
Point of care ultrasound to measure gastric contents.
Average Gastric Volume
Median volume (mL/kg) of gastric contents measured by ultrasound.
Time frame: Baseline - 5 days
Risk of Aspiration
The potential risk of aspirating stomach contents if patient underwent intubation.
Time frame: Baseline - 5 days
| Milestone | Post-pyloric | Gastric |
|---|---|---|
| Started | 16 | 29 |
| Completed | 16 | 29 |
| Not completed | 0 | 0 |
Median volume (mL/kg) of gastric contents measured by ultrasound.
| milliters per killogram | Post-pyloric | Gastric |
|---|---|---|
| Average Gastric Volume | 2.1 (1.1 to 4.5) | 0 (0 to 0.1) |
The potential risk of aspirating stomach contents if patient underwent intubation.
| Participants | Post-pyloric | Gastric |
|---|---|---|
| Low risk | 16 | 3 |
| High risk | 0 | 26 |
Collected over 5 days. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Post-pyloric | 0/16 (0%) | 0/16 (0%) | 0/16 (0%) |
| Gastric | 0/29 (0%) | 0/29 (0%) | 0/29 (0%) |
| Age, Categorical(Participants) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| <=18 years | 16 | 29 | 45 |
| Between 18 and 65 years | 0 | 0 | 0 |
| >=65 years | 0 | 0 | 0 |
| Age, Continuous(months) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| Median | 12 (4 to 122) | 4 (2 to 16) | 6 (2 to 48) |
| Sex: Female, Male(Participants) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| Female | 6 | 7 | 13 |
| Male | 10 | 22 | 32 |
| Race and Ethnicity Not Collected(Participants) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| Count of participants | — | — | 0 |
| Region of Enrollment(participants) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| United States | 16 | 29 | 45 |
| Weight(kilograms) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| Median | 10.1 (5.0 to 37.3) | 7.6 (5.5 to 12.9) | 7.9 (5.0 to 15.2) |
| Height(centimeters) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| Median | 76.1 (57.5 to 129.5) | 60 (53 to 77) | 62 (54 to 79) |
| PRISM(Participants) | Post-pyloric | Gastric | Total |
|---|---|---|---|
| Low risk | 8 | 21 | 29 |
| Moderate risk | 6 | 5 | 11 |
| Unknown | 2 | 3 | 5 |
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Feb 2021 to primary completion in Mar 2026, 60 months.
Results were first posted in Jul 2026, 4 months after primary completion.
Of 441 non-industry observational studies under Critical Illness, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 60 months is above that.
Counting every sponsor, half of 444 studies reached it within 23 months; a quarter within 12 and three quarters within 46.
Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Joseph D. Tobias